← All organizations

Iveric Bio

For profitWebsite ↗

Also known as: IVERIC BIO | IVERIC bio, Inc. | IVERIC BIO, INC. | Ophthotech Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Sep 26, 2022

Acquired by Astellas → Leo Pharma on May 1, 2023

Timeline

2000s

Jan 1, 2007
Iveric Bio— Founded

2010s

Nov 17, 2015
Leo Pharma— Now

2020s

May 1, 2023
Astellas— Acquired By
Aug 4, 2023
avacincaptad pegol— Marketing Organization
Aug 4, 2023
avacincaptad pegol— NDA Secondary Org

Drugs by trial phase (7 distinct, 19 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

avacincaptad pegol

Recent trials (21)

NCT05536297Lead sponsorPhase 3Sep 26, 2022
NCT05536297Study chairPhase 3Sep 26, 2022
NCT04435366Lead sponsorPhase 3Jun 30, 2020
NCT03374670Lead sponsorPhase 2Nov 30, 2018
NCT03364153Lead sponsorPhase 2Jan 12, 2018
NCT03362190Lead sponsorPhase 2Oct 11, 2017
NCT05571267Lead sponsorPhase 2Oct 20, 2016
NCT05571267Study directorPhase 2Oct 20, 2016
NCT02686658Lead sponsorPhase 2/Phase 3Jan 1, 2016
NCT02397954Lead sponsorPhase 2Mar 1, 2015
NCT02387957Lead sponsorPhase 2Feb 1, 2015
NCT02214628Lead sponsorPhase 2Jul 1, 2014
NCT01940887Lead sponsorPhase 3May 1, 2014
NCT02591914CollaboratorPhase 1Feb 1, 2014
NCT01940900Lead sponsorPhase 3Aug 1, 2013

Details

Founded: Princeton, NJ, US Jan 1, 2007
Last known activity: Sep 26, 2022

Notes

Formerly Ophthotech Corporation